Routine initial ownership filing, no trading or material change. Monitor for any subsequent Form 4 filings that would indicate insider transactions.
Price Chart
Executive Summary
Amir Inamdar filed a Form 3 initial statement of beneficial ownership, reporting 224,332 common shares held indirectly via Zephyr Life Sciences Ltd., 3,490 common shares directly held, and 66,668 unvested restricted share units (RSUs) held indirectly via Zephyr Life Sciences Inc. This is a routine insider ownership disclosure with no material financial impact.
Key Facts
- Form 3 filed by Amir Inamdar as an insider of Helus Pharma Inc. (HELP)
- Reports 224,332 common shares held indirectly by Zephyr Life Sciences Ltd.
- Reports 3,490 common shares held directly
- Reports 66,668 unvested RSUs held indirectly by Zephyr Life Sciences Inc.
- RSUs vest quarterly over three years from a grant on October 1, 2025
- Each RSU converts to one common share of the issuer
Financial Impact
No financial figures disclosed beyond share counts; no transaction or compensation value stated.
Risk Factors
- No material risks identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0000912282-26-001388 |
| Document: 0000912282-26-001388-index.html | 0000912282-26-001388 |
| Document: 0000912282-26-001388.txt | 0000912282-26-001388 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 6-K | $10.66 | awaiting T+20 | awaiting T+20 | $10.52 (−1.27%) |
Oct 26, 2026 1d ago | 3 | $10.36 | awaiting T+20 | awaiting T+20 | $10.52 (+1.54%) |
Oct 26, 2026 1d ago | 3 | $10.36 | awaiting T+20 | awaiting T+20 | $10.52 (+1.54%) |
Oct 23, 2026 4d ago | 3 | $10.36 | awaiting T+20 | awaiting T+20 | $10.52 (+1.54%) |
Oct 23, 2026 4d ago | 3 | $10.36 | awaiting T+20 | awaiting T+20 | $10.52 (+1.54%) |
Oct 23, 2026 4d ago | 3 | $10.36 | awaiting T+20 | awaiting T+20 | $10.52 (+1.54%) |
Oct 23, 2026 4d ago | 3 | $10.36 | awaiting T+20 | awaiting T+20 | $10.52 (+1.54%) |
Oct 21, 2026 6d ago | 6-K | $10.50 | awaiting T+20 | awaiting T+20 | $10.52 (+0.19%) |
Oct 15, 2026 12d ago | 6-K | $11.05 | awaiting T+20 | awaiting T+20 | $10.52 (−4.80%) |
Oct 15, 2026 13d ago | Press Release | $11.05 | awaiting T+20 | awaiting T+20 | $10.52 (−4.80%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers